Number of items: 13.
2024
Jhund, P. S. et al.
(2024)
Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis.
Lancet, 404(10458),
pp. 1119-1131.
(doi: 10.1016/S0140-6736(24)01733-1)
(PMID:39232490)
Yang, M. et al.
(2024)
Dapagliflozin and quality of life measured using the EuroQol 5-Dimension questionnaire in patients with HFrEF and HFmrEF/HFpEF.
European Journal of Heart Failure, 26(7),
pp. 1524-1538.
(doi: 10.1002/ejhf.3263)
(PMID:38700986)
Curtain, J. P. et al.
(2024)
Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF.
European Journal of Heart Failure, 26(6),
pp. 1383-1392.
(doi: 10.1002/ejhf.3290)
(PMID:38741283)
Kondo, T. et al.
(2024)
Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF.
Journal of the American College of Cardiology, 83(20),
pp. 1973-1986.
(doi: 10.1016/j.jacc.2024.03.385)
(PMID:38537918)
Carrasco-Marín, F. et al.
(2024)
Adherence to dietary recommendations by socioeconomic status in the United Kingdom biobank cohort study.
Frontiers in Nutrition, 11,
1349538.
(doi: 10.3389/fnut.2024.1349538)
McDowell, K. et al.
(2024)
Prognostic models for mortality and morbidity in heart failure with preserved ejection fraction.
JAMA Cardiology, 9(5),
457.
(doi: 10.1001/jamacardio.2024.0284)
(PMID:38536153)
Borumandnia, N., Rostami, M., Talebi, A. and Alavimajd, H.
(2024)
The impact of vitamin D changes during pregnancy on the development of maternal adverse events: A random forest analysis.
BMC Pregnancy and Childbirth, 24,
125.
(doi: 10.1186/s12884-024-06294-5)
(PMID:38341546)
(PMCID:PMC10858460)
2023
Boonpor, J. et al.
(2023)
Associations and predictive performance of eleven anthropometric measures with incident type 2 diabetes: a prospective cohort study from the UK Biobank.
Obesity, 31(10),
pp. 2648-2657.
(doi: 10.1002/oby.23849)
(PMID:37724055)
Shakhssalim, N., Talebi, A., Pahlevan‐Fallahy, M.‐T., Sotoodeh, K., Alavimajd, H., Borumandnia, N. and Taheri, M.
(2023)
Lifestyle and occupational risks assessment of bladder cancer using machine learning‐based prediction models.
Cancer Reports, 6(9),
e1860.
(doi: 10.1002/cnr2.1860)
(PMID:37403801)
(PMCID:PMC10480417)
Boonpor, J. et al.
(2023)
Association between walking pace and incident type 2 diabetes by adiposity levels – a prospective cohort study from the UK Biobank.
Diabetes, Obesity and Metabolism, 25(7),
pp. 1900-1910.
(doi: 10.1111/dom.15053)
(PMID:36951683)
Jhund, P. S. et al.
(2023)
Effect of dapagliflozin on total heart failure events in patients with heart failure with mildly reduced or preserved ejection fraction. A prespecified analysis of the DELIVER trial.
JAMA Cardiology, 8(6),
pp. 554-563.
(doi: 10.1001/jamacardio.2023.0711)
(PMID:37099283)
(PMCID:PMC10134044)
Talebi, A., Celis‑Morales, C. , Borumandnia, N., Abbasi, S., Pourhoseingholi, M. A., Akbari, A. and Yousefi, J.
(2023)
Predicting metastasis in gastric cancer patients: machine learning-based approaches.
Scientific Reports, 13,
4163.
(doi: 10.1038/s41598-023-31272-w)
(PMID:36914697)
(PMCID:PMC10011363)
2022
Kondo, T. et al.
(2022)
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
European Heart Journal, 43(42),
pp. 4469-4479.
(doi: 10.1093/eurheartj/ehac487)
(PMID:36017729)
(PMCID:PMC9637422)
This list was generated on Sat Nov 2 20:53:42 2024 GMT.